Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6739445 | 7402631 | I | 6739445-3 | 20100510 | 20100521 | EXP | TPA2010A02758 | TAKEDA PHARMACEUTICALS NORTH AMERICA. | 53 | YR | M | N | 160 | LBS | 20100520 | CN | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6739445 | 1013744281 | PS | ACTOS | 1 | ORAL | 30 MG, 1 IN 1 D, PER ORAL | D | D | 21073 | ||
| 6739445 | 1013767752 | C | METFORMIN HCL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6739445 | 1013744281 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6739445 | DS |
| 6739445 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6739445 | CEREBROVASCULAR ACCIDENT |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6739445 | CR |
| 6739445 | CSM |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6739445 | 1013744281 | 20090901 |